Proton pump inhibitors: New mechanisms of action.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 87, doi. 10.1111/bcpt.13237
- By:
- Publication type:
- Article
Works matching IS 1742-7835 AND VI 125 AND IP 2 AND DT 2019
Results: 12
1
2
Laparoscopic Roux‐en‐Y gastric bypass surgery influenced pharmacokinetics of several drugs given as a cocktail with the highest impact observed for CYP1A2, CYP2C8 and CYP2E1 substrates.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 123, doi. 10.1111/bcpt.13234
- By:
- Publication type:
- Article
3
Differences in preventing new‐onset cardiovascular events with statin therapy in seniors aged 75 years and over: A cohort study in the South Korean National Health Insurance Database.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 108, doi. 10.1111/bcpt.13229
- By:
- Publication type:
- Article
4
Fasudil alleviates brain damage in rats after carbon monoxide poisoning through regulating neurite outgrowth inhibitor/oligodendrocytemyelin glycoprotein signalling pathway.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 152, doi. 10.1111/bcpt.13233
- By:
- Publication type:
- Article
5
Pharmacokinetics of ferric bepectate—a new intravenous iron drug for treating iron deficiency.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 133, doi. 10.1111/bcpt.13219
- By:
- Publication type:
- Article
6
Clinical toxicology of beta‐blocker overdose in adults.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 178, doi. 10.1111/bcpt.13231
- By:
- Publication type:
- Article
7
Decreased Cytochrome P450 3A activity in palliative patients with haematological diseases: Potential impact on supportive drug therapies.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 117, doi. 10.1111/bcpt.13232
- By:
- Publication type:
- Article
8
Lung alveolar tissue destruction and protein citrullination in diesel exhaust‐exposed mouse lungs.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 166, doi. 10.1111/bcpt.13213
- By:
- Publication type:
- Article
9
Physiologically based pharmacokinetic modelling to predict exposure differences in healthy volunteers and subjects with renal impairment: Ceftazidime case study.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 100, doi. 10.1111/bcpt.13209
- By:
- Publication type:
- Article
10
Lansoprazole inhibits the cysteine protease legumain by binding to the active site.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 89, doi. 10.1111/bcpt.13230
- By:
- Publication type:
- Article
11
Issue Information.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 85, doi. 10.1111/bcpt.13068
- Publication type:
- Article
12
Wuzhi capsule regulates chloroacetaldehyde pharmacokinetics behaviour and alleviates high‐dose cyclophosphamide‐induced nephrotoxicity and neurotoxicity in rats.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2019, v. 125, n. 2, p. 142, doi. 10.1111/bcpt.13211
- By:
- Publication type:
- Article